Altre lingue NEOS AB

Azioni

NEOD

SE0021615655

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 14:32:06 31/05/2024			Variaz. 5gg	Var. 1 gen.
0,908 ^SEK	-0,22%		-9,20%	-58,73%

22/03	NeoDynamics AB (publ) annuncia il cambiamento dell'Amministratore Delegato	CI
29/02	Anna Eriksrud annuncia il desiderio di ritirarsi come CEO di NeoDynamics AB (publ)	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

NeoDynamics AB Announces Appointment of Matilda Salén as Its New Chief Executive Officer	22/03
Anna Eriksrud Announces Desire to Retire as CEO of NeoDynamics AB	29/02
NeoDynamics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
NeoDynamics AB Reports Earnings Results for the Full Year Ended December 31, 2023	16/02
Neodynamics Launches Device Registry in Germany, Cost-Effective Collection of Real-World Data	11/12
NeoDynamics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11
NeoDynamics Announces Cost Reduction Plan	13/11
NeoDynamics AB Receives New Order from Western Rhineland-Palatinate Hospital in Germany	18/10/23
NeoDynamics Soars 42% Amid First US Order for Invasive Biopsy System NeoNavia	09/08/23
NeoDynamics AB Receives First Commercial Order from Top University Hospital	09/08/23
NeoDynamics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31/07/23
Neodynamics AB Presents Results of Pulse Study At the Annual Congress of the German Society of Senology, Munich	10/07/23
NeoDynamics Plans SEK72 Million Rights Issue to Fund Commercialization, Marketing Operations	23/06/23
NeoDynamics AB Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
NeoDynamics AB Presents Final Data Set from NeoDynamics' Pulse Study Presented at the SBI Breast Imaging Symposium	05/05/23
Sweden’s NeoDynamics Launches New Biopsy Technology in US	27/04/23
Neodynamics, Inc. Announces U.S. Availability of Neonavia, the First and Only Pulse Biopsy Technology, Fda-Cleared in Breast and Axillary Lymph Node Biopsies	27/04/23
Neodynamics AB Announces Delivery of Corepulse Needles to 23 Hospitals	03/04/23
NeoDynamics Receives Chinese Patent for NeoNavia FlexiPulse	06/03/23
NeoDynamics AB Receives Chinese Patent for FlexiPulse Needle Design	06/03/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue NEOS AB

Azioni

NEOD

SE0021615655

Altre lingue

Filtri